Psychiatry & Neurology Doctors in Palmetto Bay, FL Accepting Medicare

8 Psychiatry & Neurology doctors found. Showing 1 - 8

Dr. Juan Cristobal Rondeau, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 17422 Sw 74th Ct, Palmetto Bay, FL 33157 Phone: 954-892-3851

Felix Nicolas Rodriguez, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 8230 Sw 144th St, Palmetto Bay, FL 33158 Phone: 305-209-1978

Kenneth A Butler, MD Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 8950 Sw 152nd St Ste A, Palmetto Bay, FL 33157 Phone: 305-279-2226    Fax: 786-364-6811

Dr. Juan Osvaldo Pagan, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9299 Sw 152nd St, 201, Palmetto Bay, FL 33157 Phone: 305-233-0137    Fax: 305-252-8160

Henry Michael Storper, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 9275 Sw 152nd St, Suite 108 B, Palmetto Bay, FL 33157 Phone: 305-252-0533    Fax: 305-252-0575

Dr. Elizabeth Garcia Lopez De Victoria, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 9025 Sw 160 Terrace, Palmetto Bay, FL 33157 Phone: 615-345-5400

Dr. Abiezer Rodriguez Centeno, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 9333 Sw 152nd St, Palmetto Bay, FL 33157 Phone: 305-251-2500

Robert F Cullen Jr., MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 15715 S Dixie Hwy Ste 407, Palmetto Bay, FL 33157 Phone: 305-253-4600    Fax: 305-253-4602

News Archive

FDA clears rapid test for the detection of influenza A/H5N1

The U.S. Food and Drug Administration today cleared for marketing a new, more rapid test for the detection of influenza A/H5N1, a disease-causing subtype of the avian influenza A virus that can infect humans.

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

A new study from Belgian researchers shows that antiviral drug Favipiravir could have a weak effect against the dreaded novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as seen in hamster models. However, the study also finds there is no efficacy of the much-touted drug Hydroxychloroquine.

Patheon adds development and manufacturing softgel capability in Cincinnati facility

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.

UT Southwestern physicians eliminate sociodemographic disparities in testicular cancer patients

By offering the same level of care and expertise to two very different populations, UT Southwestern physicians were able to eliminate the sociodemographic disparities in survival and cancer recurrence rates typically seen nationally in testicular cancer patients.

Read more Medical News

› Verified 9 days ago